期刊
JOURNAL OF CONTROLLED RELEASE
卷 322, 期 -, 页码 555-565出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2020.03.039
关键词
Extracellular vesicles; Exosomes; Microparticles; Tumor-targeted delivery
资金
- National Basic Research Program of China [2018YFA0208900]
- National Natural Science Foundation of China [81803018, 81773653, 81672937, 81974459, 81771978]
- Program for HUST Academic Frontier Youth Team [2018QYTD01]
- Program for Changjiang Scholars and Innovative Research Team in University [IRT13016]
Extracellular vesicles (EVs) are membrane vesicles with size of nanometers to several micrometers, which are released by most eukaryotic and prokaryotic cells. Recently, EVs-based nanomedicines have achieved remarkable attentions. Five features need to be satisfied for EVs-based nanomedicine to achieve desirable anticancer activity after systemic administration, including long circulation, enhanced tumor accumulation, deep tumor penetration, efficient cellular internalization and drug release. In this review, we summarize recently reported EVs-based nanomedicines for efficient drug delivery based on our defined five features principle theory. Even though EVs-based nanomedicines are in infancy, it is expectable that they exhibit promising prospects for cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据